Stay updated on Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page.

Latest updates to the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page
- Check4 days agoChange DetectedA site-wide notice about a lapse in government funding was added and the page revision was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check12 days agoChange DetectedA glossary toggle was added and color-coded change highlights (green for additions, red for deletions) were implemented on the Record History page. The revision banner now shows 'Revision: v3.4.0' and mentions 'No FEAR Act Data', replacing the previous wording 'No FEAR Act data' and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check19 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer. No substantive content or navigation changes were observed.SummaryDifference0.0%

- Check48 days agoChange DetectedFooter updates: the HHS Vulnerability Disclosure link was removed, and the revision history shows v3.3.2 removed and v3.3.3 added.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now includes Revision: v3.3.2 and removes Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedA new revision label v3.3.1 was added and the previous revision v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Subcutaneous Semaglutide in NASH Clinical Trial page.